Decheng Capital LLC
CIK 2010850
13F filing for Q2 2026・No. 3,134
- Holdings
- US$731.75M
- Quarter change
- +US$70.43M
- Entries
- 14
- Net bought (estimate)
- −US$5.58M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 1
- Sold out 1
- Cut 2
- Added 1
- Corporate actions 0
- Unchanged 10
Largest holdings
14 stocks worth US$731.75M, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| CG ONCOLOGY INCCOM | Unchanged | 6,371,669 | US$452.71M | 61.87% |
| NUVBNuvation Bio Inc.COM | Unchanged | 25,954,439 | US$147.42M | 20.15% |
| AARDVARK THERAPEUTICS INCCOM | Unchanged | 3,917,299 | US$22.56M | 3.08% |
| Aclaris Therapeutics, Inc.COM | Unchanged | 4,041,736 | US$21.38M | 2.92% |
| Upstream Bio Inc.COM | Unchanged | 2,724,868 | US$18.86M | 2.58% |
| Arcus Biosciences, IncCOM | Cut | 464,779 | US$14.33M | 1.96% |
| Equillium Inc.COM | Unchanged | 4,447,308 | US$14.23M | 1.94% |
| RVMDREVOLUTION MEDICINES INC(NSM)COM | AddedSplit 1:2 | 52,667 | US$9.86M | 1.35% |
| Lyell Immunopharma, Inc.COM | Unchanged | 692,050 | US$9.72M | 1.33% |
| BeyondSpring Inc.SHS | Unchanged | 3,800,702 | US$6.65M | 0.91% |
Sign in (free) to see its 14 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 14, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.